IPOs
PolyPid, which develops an antibiotic coating for bone repair, has delayed its IPO. The company had planned to raise as much as $24 million...
Hi, what are you looking for?
PolyPid, which develops an antibiotic coating for bone repair, has delayed its IPO. The company had planned to raise as much as $24 million...
Vitamin D deficiency is not just harmful to physical health–it also might impact mental health, according to a team of researchers that has found...
On CNBC’s Stop Trading segment, Jim Cramer said he had a “bone to pick” with Goldman Sachs about its downgrade of Ulta Salon from...
In 2014 we’ve finally run out of euphemisms, because, frankly, they can’t keep up. Reality is imitating Art way faster than Art is doing...
Israel’s Cell Source Inc., an immunotherapy and regenerative medicine company, announced that its Megadose Drug Combination which assists in bone marrow transplants has been...
– A big victory by German stallion Protectionist in the Melbourne Cup on Tuesday was overshadowed by the deaths of two horses after...
Turns out your mom was right: Scratching an itch only makes it worse. New research from scientists at Washington University School of Medicine in...
PolyPid, which develops an antibiotic coating for bone repair, has filed with the SEC for an initial public offering on the NASDAQ in which...
Treatment approaches to reduce the risk of bone complications (metastasis) associated with breast cancer may be one step closer to becoming a reality. According...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the US Food and Drug Administration has designated...